A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects

NCT00537420 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

551

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Nasal Placebo
DRUG: Placebo Capsule
DRUG: PYY3-36
DRUG: PYY3-36
DRUG: PYY3-36
DRUG: Sibutramine

Sponsor

Nastech Pharmaceutical Company, Inc.